國立高雄大學圖資館 |

Language: English

Back

Stroke revisiteddyslipidemia in stroke /

Kang, Min Kyoung.

Stroke revisiteddyslipidemia in stroke /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Stroke revisitededited by Seung-Hoon Lee, Min Kyoung Kang.
Reminder of title:	dyslipidemia in stroke /
other author:	Lee, Seung-Hoon.
Published:	Singapore :Springer Singapore :2021.
Description:	xiii, 219 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Cerebrovascular disease.
Online resource:	https://doi.org/10.1007/978-981-16-3923-4
ISBN:	9789811639234

Stroke revisiteddyslipidemia in stroke /
Stroke revisiteddyslipidemia in stroke /[electronic resource] :edited by Seung-Hoon Lee, Min Kyoung Kang. - Singapore :Springer Singapore :2021. - xiii, 219 p. :ill., digital ;24 cm. - Stroke revisited,2522-5596. - Stroke revisited..

Part 1 Basic Science: Dyslipidemia and Stroke -- 1 Role of Dyslipidemia in Atherosclerosis -- 2 Effects of Dyslipidemia on the Cerebral vessels -- Part 2 Clinical Significance of Dyslipidemia in Stroke -- 3 Impact of Dyslipidemia on Ischemic Stroke -- 4 Dyslipidemia and Hemorrhagic Stroke -- 5 Clinical biomarkers of Dyslipidemia. Part 3 Treatment of Dyslipidemia in Stroke Patients -- 6 Therapeutic Lifestyle Modification -- 7 Statins -- 8 Ezetimibe -- 9 Fibrate and Niacin -- 10 Fish Oils -- 11 PCSK9 inhibiting monoclonal antibodies -- 12 PCSK9 inhibiting siRNA -- 13 Understanding of Clinical Practice Guidelines for Dyslipidemia -- Part 4 Management of Dyslipidemia in Clinical Practice of Stroke -- 14 Practical Management of Dyslipidemia in Stroke Patients -- 15 Practical Dyslipidemia Management in Stroke-specific Situations -- 16 Dyslipidemia in Women: Etiology and Management -- 17 Safety Considerations of Pharmacological Treatment.

This book presents state of the art knowledge on dyslipidemia in stroke, covering both basic and clinical aspects in detail. The focus is in particular on two major themes: the clinical significance of dyslipidemia in stroke and the treatment of dyslipidemia in stroke patients. Readers will find up-to-date information on lipid metabolism, biomarkers, and advances in treatment options, including novel biologic drugs. Specific management considerations and pitfalls are also discussed. The individual components of pathophysiology, treatment, and key issues are addressed with the aid of complementary illustrations that facilitate understanding of practical aspects and enable the reader to retrieve fundamental information quickly. This book is timely in bringing together within one volume the most important current knowledge on dyslipidemia in stroke. It will be invaluable for stroke physicians, pharmacists, and students seeking to acquire up-to-date knowledge.

ISBN: 9789811639234

Standard No.: 10.1007/978-981-16-3923-4doiSubjects--Topical Terms:

233618
Cerebrovascular disease.

LC Class. No.: RC388.5 / .S77 2021

Dewey Class. No.: 616.81

Stroke revisiteddyslipidemia in stroke /
LDR:02943nmm a2200337 a 4500 001 608235
003 DE-He213
005 20210828121519.0
006 m d
007 cr nn 008maaau
008 220119s2021 si s 0 eng d
020 $a 9789811639234 $q (electronic bk.)
020 $a 9789811639227 $q (paper)
024 7 $a 10.1007/978-981-16-3923-4 $2 doi
035 $a 978-981-16-3923-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC388.5 $b .S77 2021
072 7 $a MJN $2 bicssc
072 7 $a MED056000 $2 bisacsh
072 7 $a MKJ $2 thema
082 0 4 $a 616.81 $2 23
090 $a RC388.5 $b .S921 2021
245 0 0 $a Stroke revisited $h [electronic resource] : $b dyslipidemia in stroke / $c edited by Seung-Hoon Lee, Min Kyoung Kang.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a xiii, 219 p. : $b ill., digital ; $c 24 cm.
490 1 $a Stroke revisited, $x 2522-5596
505 0 $a Part 1 Basic Science: Dyslipidemia and Stroke -- 1 Role of Dyslipidemia in Atherosclerosis -- 2 Effects of Dyslipidemia on the Cerebral vessels -- Part 2 Clinical Significance of Dyslipidemia in Stroke -- 3 Impact of Dyslipidemia on Ischemic Stroke -- 4 Dyslipidemia and Hemorrhagic Stroke -- 5 Clinical biomarkers of Dyslipidemia. Part 3 Treatment of Dyslipidemia in Stroke Patients -- 6 Therapeutic Lifestyle Modification -- 7 Statins -- 8 Ezetimibe -- 9 Fibrate and Niacin -- 10 Fish Oils -- 11 PCSK9 inhibiting monoclonal antibodies -- 12 PCSK9 inhibiting siRNA -- 13 Understanding of Clinical Practice Guidelines for Dyslipidemia -- Part 4 Management of Dyslipidemia in Clinical Practice of Stroke -- 14 Practical Management of Dyslipidemia in Stroke Patients -- 15 Practical Dyslipidemia Management in Stroke-specific Situations -- 16 Dyslipidemia in Women: Etiology and Management -- 17 Safety Considerations of Pharmacological Treatment.
520 $a This book presents state of the art knowledge on dyslipidemia in stroke, covering both basic and clinical aspects in detail. The focus is in particular on two major themes: the clinical significance of dyslipidemia in stroke and the treatment of dyslipidemia in stroke patients. Readers will find up-to-date information on lipid metabolism, biomarkers, and advances in treatment options, including novel biologic drugs. Specific management considerations and pitfalls are also discussed. The individual components of pathophysiology, treatment, and key issues are addressed with the aid of complementary illustrations that facilitate understanding of practical aspects and enable the reader to retrieve fundamental information quickly. This book is timely in bringing together within one volume the most important current knowledge on dyslipidemia in stroke. It will be invaluable for stroke physicians, pharmacists, and students seeking to acquire up-to-date knowledge.
650 0 $a Cerebrovascular disease. $3 233618
650 1 4 $a Neurology. $3 211583
700 1 $a Lee, Seung-Hoon. $3 791426
700 1 $a Kang, Min Kyoung. $3 905577
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Stroke revisited. $3 791427
856 4 0 $u https://doi.org/10.1007/978-981-16-3923-4
950 $a Medicine (SpringerNature-11650)